BIOMARKERS AND DISEASE MODIFICATION IN PD: TARGETING ALPHA-SYNUCLEIN, LRRK2 AND GBA

Name: BIOMARKERS AND DISEASE MODIFICATION IN PD: TARGETING ALPHA-SYNUCLEIN, LRRK2 AND GBA
Start: 2027-03-19T13:50
End: 2027-03-19T14:50
Location: Centre de Convencions Internacional de Barcelona

AD/PD 2027 – Advances in Science & Therapy · 19 March 2027 · 13:50–14:50 · Hall 115+116

BIOMARKERS AND DISEASE MODIFICATION IN PD: TARGETING ALPHA-SYNUCLEIN, LRRK2 AND GBA was a session at AD/PD 2027 – Advances in Science & Therapy on 19 March 2027 in Barcelona, with 3 speakers on record.

Speakers

Jaime Eberling — Moderator Michael J. Fox Foundation
Brit Mollenhauer — Panelist Paracelsus-Elena-Klinik Kassel
Ken Marek — Moderator